Journal ArticleDOI
The immunology of asthma
Bart N. Lambrecht,Hamida Hammad +1 more
Reads0
Chats0
TLDR
Results from in-depth molecular studies of mouse models in light of the results from the first clinical trials targeting key cytokines in humans are discussed and the extraordinary heterogeneity of asthma is described.Abstract:
Asthma is a common disease that affects 300 million people worldwide. Given the large number of eosinophils in the airways of people with mild asthma, and verified by data from murine models, asthma was long considered the hallmark T helper type 2 (T(H)2) disease of the airways. It is now known that some asthmatic inflammation is neutrophilic, controlled by the T(H)17 subset of helper T cells, and that some eosinophilic inflammation is controlled by type 2 innate lymphoid cells (ILC2 cells) acting together with basophils. Here we discuss results from in-depth molecular studies of mouse models in light of the results from the first clinical trials targeting key cytokines in humans and describe the extraordinary heterogeneity of asthma.read more
Citations
More filters
Journal ArticleDOI
Chlorella vulgaris α-L-arabino-α-L-rhamno-α,β-D-galactan structure and mechanisms of its anti-inflammatory and anti-remodelling effects.
Peter Capek,Mária Matulová,Martina Sutovska,Martina Sutovska,Jana Barboríková,Miroslava Molitorisová,Ivana Kazimierová +6 more
TL;DR: Factors point to the anti-remodelling effect of Chlorella EPS and suggest its possible application in the treatment of asthma and chronic obstructive pulmonary disorder.
Journal ArticleDOI
The dual function of ILC2: From host protection to pathogenic players in type 2 asthma.
Laura Maggi,Alessio Mazzoni,Manuela Capone,Francesco Liotta,Francesco Annunziato,Lorenzo Cosmi +5 more
TL;DR: In this paper, the authors performed an excursus on phenotypical and functional properties on both human and mouse ILC2, in physiological and pathological conditions (mainly in type 2 asthma), considering this cell subset as target for specific therapeutic strategies.
Journal ArticleDOI
Deciphering Asthma Biomarkers with Protein Profiling Technology
TL;DR: In this paper, the authors discuss potential asthma biomarkers involved in the pathophysiologic process and eventual pathogenesis of asthma, how these biomarkers are being utilized, and how further testing methods might help improve the diagnosis and treatment strain that current asthma patients suffer.
Journal ArticleDOI
Serum exosome inflamma‐miRs are surrogate biomarkers for asthma phenotype and severity
S. Vázquez-Mera,L. Martelo-Vidal,P. Miguéns-Suárez,Paula Saavedra-Nieves,Pilar Arias,Coral González-Fernández,Mar Mosteiro-Añón,María Dolores Corbacho-Abelaira,Marina Blanco-Aparicio,P Méndez-Brea,Francisco J. Salgado,Juan-José Nieto-Fontarigo,Francisco-Javier González-Barcala +12 more
TL;DR: Immune-related miRNAs, includingmiR-21-5p, miR-126-3p,MiR-146a- 5p, and miR -215-5P can be used as clinically relevant non-invasive biomarkers of the phenotype/endotype and severity of asthma.
Journal ArticleDOI
Airway epithelial integrin β4 suppresses allergic inflammation by decreasing CCL17 production.
Lin Yuan,Xun Zhang,Ming Yang,Ming Yang,Xizi Du,Leyuan Wang,Shuangyan Wu,Mengping Wu,Zhen Duan,Gelei Xiao,Yizhou Zou,Yang Xiang,Xiangping Qu,Huijun Liu,Ling Qin,Qingwu Qin,Xiaoqun Qin,Chi Liu +17 more
TL;DR: The involvement of ITGB4 deficiency in the development of Th2 responses of allergic asthma by down-regulation of EGFR and CCL17 pathway in AECs is demonstrated.
References
More filters
Journal ArticleDOI
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
Douglas S. Robinson,Qutayba Hamid,Sun Ying,Anne Tsicopoulos,J. Barkans,Andrew Bentley,Christopher Corrigan,Stephen R. Durham,A. B. Kay +8 more
TL;DR: Atopic asthma is associated with activation in the bronchi of the interleukin-3, 4, and 5 and GM-CSF gene cluster, a pattern compatible with predominant activation of the TH2-like T-cell population.
Journal ArticleDOI
Interleukin-13: Central Mediator of Allergic Asthma
Marsha Wills-Karp,Jackie Luyimbazi,Xueying Xu,Brian Schofield,Tamlyn Neben,Christopher L. Karp,Debra D. Donaldson +6 more
TL;DR: In this paper, the type 2 cytokine IL-13, which shares a receptor component and signaling pathways with IL-4, was found to be necessary and sufficient for the expression of allergic asthma.
Journal ArticleDOI
Eosinophilic inflammation in asthma.
Jean Bousquet,Pascal Chanez,J.-Y. Lacoste,G. Barneon,N Ghavanian,I. Enander,Per Venge,Staffan Ahlstedt,J Simony-Lafontaine,P. Godard +9 more
TL;DR: Eosinophilic inflammation of the airways is correlated with the severity of asthma and these cells are likely to play a part in the epithelial damage seen in this disease.
Journal Article
Interleukin-13: Central mediator of allergic asthma
Marsha Wills-Karp,Jackie Luyimbazi,Xueying Xu,Brian Schofield,Tamlyn Neben,Christopher L. Karp,Debra D. Donaldson +6 more
TL;DR: In this article, the type 2 cytokine IL-13, which shares a receptor component and signaling pathways with IL-4, was found to be necessary and sufficient for the expression of allergic asthma.
Journal ArticleDOI
Asthma phenotypes: the evolution from clinical to molecular approaches
TL;DR: Ongoing studies of large-scale, molecularly and genetically focused and extensively clinically characterized cohorts of asthma should enhance the ability to molecularly understand these phenotypes and lead to more targeted and personalized approaches to asthma therapy.
Related Papers (5)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung,Sally E. Wenzel,Jan Brozek,Andrew Bush,Mario Castro,Peter J. Sterk,Ian M. Adcock,Eric D. Bateman,Elisabeth H. Bel,Eugene R. Bleecker,Louis-Philippe Boulet,Christopher E. Brightling,Pascal Chanez,Sven-Erik Dahlén,Ratko Djukanovic,Urs Frey,Mina Gaga,Peter G. Gibson,Qutayba Hamid,Nizar N. Jajour,Thais Mauad,Ronald L. Sorkness,W. Gerald Teague +22 more